US4577301090
US4577301090
Inspire Medical Systems, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.99B EUR | 1.29B EUR | 1.49B EUR | 2.64B EUR |
Enterprise Value | 1.64B EUR | 1.19B EUR | 1.42B EUR | 2.56B EUR |
Valuation Multiples | ||||
Trailing P/E | 15.17x | 9.55x | 11.33x | 18.51x |
Forward P/E | 44.59x | -- | -- | -- |
Price to Sales | 2.22x | 1.43x | 1.62x | 3.71x |
Price to Book | 2.41x | 1.56x | 1.87x | 3.37x |
EV/Revenue | 1.82x | 1.33x | 1.55x | 3.61x |
EV/EBITDA | 22.94x | 14.97x | 18.74x | 35.8x |
Price to FCF (P/FCF) | 21.04x | 11.01x | 15.36x | 28.16x |
EV/FCF | 17.29x | 10.17x | 14.64x | 27.39x |
FCF Yield | 4.75% | 9.08% | 6.51% | 3.55% |